Dr KUMARASWAMY GANDLA
Also known as: Dr Kumaraswamy Gandla
Chaitanya (Deemed to be University), JNTUK
About
Prof. Kumaraswamy Gandla, M.Pharm.,PGDAW, Ph.D. currently working as a Dean and BoS Chairperson, Department of Pharmacy, Chaitanya Deemed to be University, Hyderabad, Telangana, India Dr. Kumaraswamy received his Doctoral degree from Jawaharlal Nehru Technological University, Kakinada, Andhra Pradesh. He is having 17 years of experience in working with various industry, research and academic institutes. 75 M.Pharmacy students and 5 Research Scholars were Awarded under his supervision. Currently 07 Research Scholars pursuing Ph.D. under his supervision. He has contributed extensively to the field of pharmaceutical technology with more than 250 publications with cumulative impact factor of 100. His publications are appearing in several reputed National & International journals etc. Dr Kumaraswamy filed and published 15 patents with various patent agencies. He authored 09 books & chapters with various publishers such as Springer, Elsevier, Taylor and Francis Group and Wiley.
You may contact the author at: [email protected]
Mobile:+91-9000973789
Employment
-
Chaitanya (Deemed to be University) Professor and Dean2021 - 2037
Education
-
JNTUK Ph.D.2010 - 2015
Projects & Funding
Projects & funding information is unavailable.
Publications (63)
- Green and Robust RP-HPLC for Simultaneous Quantification of Gallic, Ferulic, and Caffeic Acids in Human Plasma via Box–Behnken Design-Based Optimization Save
- Quality by design-assisted development and validation of a sustainable LC–MS/MS method for simultaneous quantification of berahyaluronidase alfa and pembrolizumab in rat plasma: Pharmacokinetic application and comprehensive greenness assessment Save
- Tumour-Targeted Delivery of Capecitabine Exploiting Alginate-g-P(NIPAAm-co-NVP): A Stimuli-Responsive Smart Carrier System Save
- Exploration of Solid Lipid Nanoparticles-Loaded Films as a Wound Healing Drug Delivery System: In Vitro and In Vivo Studies Save
- Development of an LC–ESI–MS/MS Method for the Quantification of Tucatinib in K2EDTA Human Plasma and Its Validation Save
- Stability-Indicating UPLC Method Development and Validation for Sulfamethoxazole and Trimethoprim Injection with Comprehensive Forced Degradation Profiling Save
- Computational design and molecular insights into acetylcholinesterase inhibitors from Aristolochia indica for Alzheimer’s disease therapy Save
- Exploring compound suitability and employing DFT calculations, molecular docking, and dynamics simulation to investigate potent compounds from podophyllum medicinal plants for breast cancer therapy Save
- Applications of magnetic nanomaterials in the fabrication of lateral flow assays toward increasing performance of food safety analysis: Recent advances Save
- Natural polymers as potential P-glycoprotein inhibitors: Pre-ADMET profile and computational analysis as a proof of concept to fight multidrug resistance in cancer Save